Confidence is growing that COVID-19 vaccines authorized for use in the U.S. are holding their own against the coronavirus variants now in circulation.
“Everything we’ve seen with the variants should provide marked reassurance, as far as the protection that is afforded by vaccines — particularly the vaccines that we have in the United States,” said Dr. Eric Topol, director of the Scripps Research Translational Institute in La Jolla.
The upbeat view is accompanied by a growing sense that California is emerging from the worst of the pandemic. For weeks, California has reported one of the lowest per-capita daily coronavirus case counts of any state in the U.S.
Studies have offered reassurance that existing vaccines work well against the two most dominant strains in California — the one first identified in the United Kingdom (B.1.1.7) and the homegrown variant identified in California (B.1.427/B.1.429).
Read the full story on LATimes.com.
